Technology ❯ Biotechnology

Pharmaceuticals

Drug Development Vaccine Development Drug Discovery Drug Design Drug Delivery Systems Neurological Disorders Vaccine Technology Manufacturing Market Reactions Antivenom Technology Patent Protection Medical Devices Agroindustry Cosmetic Products Clinical Research AI Innovative Treatments Clinical Trials Therapeutic Development Cosmetic Enhancement Vaccines Drug Approval Antibodies Preventive Medicine Phytopharmaceuticals mRNA Technology

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

A successful late‑stage readout may clear the way for regulatory filings while full efficacy numbers, survival data and manufacturing plans are still pending.

Erasca Faces Securities Class Actions After April Patent Claim and Patient Death Disclosures

First Patient Dosed in Human Trial for Cell 'Rejuvenation' Therapy

Regeneron Strikes Parabilis Deal to Develop Antibody-Helicon Drugs

Cornell Study Shows Reversible Male Contraception by Targeting Meiosis in Mice

Mushrooms Evolved Psilocybin Two Ways, Lab Study Confirms

Cambridge Researchers Demonstrate Tumor-Triggered Two-Part STING Prodrug

2025 Lasker-DeBakey Award Honors Scientists Behind Trikafta’s Cystic Fibrosis Breakthrough

Commerce Department Weighs Annual 1–5% Tax on Patent Valuations